Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 47.6M | 45.3M | 42.8M | 51.8M |
| Cost of revenue | 2.9M | 4.8M | 2.8M | 2.4M |
| Gross profit | 44.7M | 40.5M | 40.0M | 49.4M |
| Operating expense | ||||
| Research & development | 6.6M | 50.1M | 4.4M | 5.7M |
| Selling general and admin | 20.2M | 18.8M | 25.6M | 24.5M |
| Other operating expenses | — | — | — | — |
| Operating income | 9.7M | -36.7M | 1.7M | 11.0M |
| Non operating interest income | ||||
| Income | 1.6M | 1.8M | 1.9M | 1.3M |
| Expense | 1.2M | 867K | 883K | 741K |
| Other income expense | 1.0M | -14.4M | -41.9M | -17.9M |
| Pretax income | 11.2M | -50.2M | -39.2M | -6.3M |
| Tax provision | 6.4M | -7.7M | -8.1M | 833K |
| Net income | 4.8M | -42.5M | -31.1M | -7.2M |
| Basic EPS | 0.3 | -2.2 | -1.6 | -0.4 |
| Diluted EPS | 0.2 | -2.2 | -1.6 | -0.4 |
| Basic average shares | 19.3M | 19.2M | 19.0M | 18.4M |
| Diluted average shares | 19.9M | 19.2M | 19.0M | 18.4M |
| EBITDA | 21.2M | -28.6M | 5.5M | 8.8M |
| Net income from continuing op. | 4.8M | -42.5M | -31.1M | -7.2M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |